Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America as represented by the Secretary of the Department of”

389 pharma patents match "The United States of America as represented by the Secretary of the Department of" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 389
Index total 30,257
Page 1 / 17

Quick answer

This filtered view shows 389 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Department of" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

389 results for “The United States of America as represented by the Secretary of the Department of” · 30,257 patents in full index Clear search

  1. US 12228582

    Method and apparatus for testing near infrared-photoimmunotherapy treatment

    The United States of America as Represented By The Secretary of the Department of Health and Human · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted

  2. US 12201685

    Methods of modulating immune responses with cationic lipid vaccine compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted

  3. US 12005115

    Epstein-barr virus vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted

  4. US 11959096

    Methods for selective inhibition of pluripotent stem cells

    The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  5. US 11890340

    Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted

  6. US 11865172

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  7. US 11497803

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted

  8. US 11325978

    Compositions and methods for treating beta-globinopathies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 10, 2022 · Expires May 5, 2042

    granted

  9. US 11160859

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  10. US 10898565

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  11. US 10695414

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  12. US 10485879

    Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues

    Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  13. US 10314908

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as represented by the Secretary of the Department of · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  14. US 10258686

    Materials and methods for respiratory disease control in canines

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEAS CONTROL AND PREVENTION · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  15. US 10213445

    Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  16. US 10137136

    Methods for inhibiting muscle atrophy

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  17. US 10092637

    Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  18. US 10093710

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  19. US 10064933

    Recombinant rift valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  20. US 10052374

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  21. US 10039741

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  22. US 10034936

    Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  23. US 10004800

    Antibody evolution immunogens

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  24. US 9944951

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.